Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lotte Group
Pharma
Eisai, Takeda, BIOSECURE—Fierce Pharma Asia
BMS returned Eisai's FRα-targeted ADC. Takeda will lay off 220 employees in MA. The U.S. House Speaker pledged a vote on the BIOSECURE Act this year.
Angus Liu
Jul 12, 2024 9:05am
Lotte Biologics breaks ground on $3.3B Korean production plant
Jul 8, 2024 2:55pm
Lotte Biologics, Merck KGaA partner for biopharma production
Jun 3, 2024 1:38pm
BeiGene, Legend, Eisai-Biogen—Fierce Pharma Asia
Jul 8, 2022 10:29am
Lotte is telegraphing plans to grow a former BMS plant
Jul 7, 2022 8:58am
MilliporeSigma to help Lotte stand up biologics production biz
Jul 1, 2022 10:01am
